Baudin Florian, Benzenine Eric, Mariet Anne-Sophie, Ben Ghezala Inès, Bron Alain M, Daien Vincent, Korobelnik Jean François, Quantin Catherine, Creuzot-Garcher Catherine
Department of Ophthalmology, University Hospital, Dijon, France; Cerebral and Cardiovascular Epidemiology, and Physiopathology, Dijon, France.
Biostatistics and Bioinformatics (DIM), University Hospital, Dijon, France; Bourgogne Franche-Comté University, Dijon, France.
Ophthalmol Retina. 2022 Jun;6(6):442-449. doi: 10.1016/j.oret.2022.01.022. Epub 2022 Feb 5.
To describe the causes of postoperative acute endophthalmitis at the national level longitudinally.
Cohort study from 2009 to 2018 in France.
Patients diagnosed with acute endophthalmitis after intraocular procedures.
The French medical-administrative database was used. Endophthalmitis cases and intraocular procedures were identified based on billing codes in all French hospitals and private practices.
The incidence of acute endophthalmitis within 42 days of the procedure.
From January 1, 2009, to October 31, 2018, 7522 cases of acute endophthalmitis occurred after 14 438 854 intraocular procedures. Most cases occurred after standalone cataract surgery (4808 cases for 7 316 077 procedures; 63.92%), followed by after intravitreal (IVT) injections (1296 cases for 5 455 631 IVT injections; 17.23%), vitreoretinal surgery (698 for 442 263 procedures; 9.28%), anterior segment surgery (245 cases; 3.26%), combined cataract and vitreoretinal surgery (191 cases; 2.54%), cornea surgery (142 cases; 1.89%), and glaucoma surgery (80 cases; 1.06%). The overall incidence of acute endophthalmitis was 1 per 1920 procedures (0.0521%; 95% confidence interval [CI], 0.0520-0.0522). The surgery with the highest incidence of endophthalmitis was scleral and globe surgery, with an incidence of 0.1827% (95% CI, 0.1757-0.1898), followed by vitreoretinal surgery combined with cataract surgery, with an incidence of 0.1685% (95% CI, 0.1663-0.1706). The incidence of endophthalmitis after IVT injections was stable over the study period, and patients receiving IVT injections were the oldest, aged 75.4 years (standard deviation, 12.0 years; P < 0.001). The onset of endophthalmitis after IVT procedures, i.e, after receiving IVT injections or undergoing vitreoretinal surgery, was earlier than that after the other procedures (P < 0.001).
The profile of patients referred for acute endophthalmitis has been evolving over the past decade, with a decrease in the raw number of endophthalmitis cases after cataract surgery as opposed to an increase in the number of patients presenting with endophthalmitis after IVT injections.
纵向描述国家层面术后急性眼内炎的病因。
2009年至2018年在法国进行的队列研究。
眼内手术后被诊断为急性眼内炎的患者。
使用法国医疗行政数据库。根据法国所有医院和私人诊所的计费代码识别眼内炎病例和眼内手术。
手术后42天内急性眼内炎的发生率。
从2009年1月1日至2018年10月31日,14438854例眼内手术后发生7522例急性眼内炎。大多数病例发生在单纯白内障手术后(7316077例手术中有4808例;63.92%),其次是玻璃体内(IVT)注射后(5455631次IVT注射中有1296例;17.23%)、玻璃体视网膜手术(442263例手术中有698例;9.28%)、眼前节手术(245例;3.26%)、白内障与玻璃体视网膜联合手术(191例;2.54%)、角膜手术(142例;1.89%)和青光眼手术(80例;1.06%)。急性眼内炎的总体发生率为每1920例手术1例(0.0521%;95%置信区间[CI],0.0520 - 0.0522)。眼内炎发生率最高的手术是巩膜和眼球手术,发生率为0.1827%(95%CI,0.1757 - 0.1898),其次是玻璃体视网膜手术联合白内障手术,发生率为0.1685%(95%CI,0.1663 - 0.1706)。在研究期间,IVT注射后眼内炎的发生率稳定,接受IVT注射的患者年龄最大,为75.4岁(标准差,12.0岁;P < 0.001)。IVT操作后(即接受IVT注射或进行玻璃体视网膜手术后)眼内炎的发病早于其他操作后(P < 0.001)。
过去十年中,因急性眼内炎就诊的患者情况一直在演变,白内障手术后眼内炎病例的原始数量有所下降,而IVT注射后出现眼内炎的患者数量有所增加。